Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.

  • Authors : Chen YC; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine

Subjects: Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/therapy ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/pathology Folfox protocol

  • Source: PloS one [PLoS One] 2021 Nov 02; Vol. 16 (11), pp. e0259460. Date of Electronic Publication: 2021 Nov 02 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer.

  • Authors : Huang CW; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.; Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/metabolism ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2021 Jul 27; Vol. 22 (15). Date of Electronic Publication: 2021 Jul 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial.

  • Authors : Ma CJ; Division of Digestive and General Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Camptothecin/Camptothecin/Camptothecin/*analogs & derivatives ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy IFL protocol

  • Source: Trials [Trials] 2019 Dec 19; Vol. 20 (1), pp. 751. Date of Electronic Publication: 2019 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

×
Academic Journal

Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.

  • Authors : Chen SH; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cetuximab/Cetuximab/Cetuximab/*administration & dosage

  • Source: BMC cancer [BMC Cancer] 2019 Jun 28; Vol. 19 (1), pp. 640. Date of Electronic Publication: 2019 Jun 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

×
Academic Journal

R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma.

  • Authors : Messmer M; a Department of Oncology , Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.; Tsai HL

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use; Lymphoma, B-Cell/Lymphoma, B-Cell/Lymphoma, B-Cell/*drug therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2019 May; Vol. 60 (5), pp. 1261-1265. Date of Electronic Publication: 2019 Jan 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.

  • Authors : Yeh YS; Division of Trauma and Critical Care, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Subjects: Colectomy*/Colectomy*/Colectomy*/adverse effects ; Colectomy*/Colectomy*/Colectomy*/mortality; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*administration & dosage

  • Source: Trials [Trials] 2017 Apr 26; Vol. 18 (1), pp. 191. Date of Electronic Publication: 2017 Apr 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

×
Academic Journal

Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.

  • Authors : Huang CM; Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Subjects: Chemoradiotherapy* ; Neoadjuvant Therapy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Folfox protocol

  • Source: Radiation oncology (London, England) [Radiat Oncol] 2017 Mar 07; Vol. 12 (1), pp. 48. Date of Electronic Publication: 2017 Mar 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X

تفاصيل العنوان

×
Academic Journal

Prospective analysis of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trial.

  • Authors : Yeh YS; Division of Trauma, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Division of Gastroenterology and General Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. .

Subjects: Polymorphism, Genetic* ; Promoter Regions, Genetic*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use IFL protocol

  • Source: Trials [Trials] 2016 Jan 25; Vol. 17, pp. 46. Date of Electronic Publication: 2016 Jan 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

×
Academic Journal

Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.

  • Authors : Lu CY; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Tsai HL

Subjects: Neoplastic Cells, Circulating*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood Folfox protocol

  • Source: British journal of cancer [Br J Cancer] 2013 Mar 05; Vol. 108 (4), pp. 791-7. Date of Electronic Publication: 2013 Feb 19.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Burkitt Lymphoma/Burkitt Lymphoma/Burkitt Lymphoma/*drug therapy ; Leukemia/Leukemia/Leukemia/*drug therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2013 Mar; Vol. 54 (3), pp. 483-90. Date of Electronic Publication: 2012 Aug 17.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
  • 1-10 ل  10 نتائج ل ""Tsai HL""